Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
Evanthia Galanis(Mayo Clinic in Arizona), Daniel J. Walsh(University College Cork)
Cited by 695
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
|Neuro-Oncology|2015|665
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
|Neuro-Oncology|2020|258